Back to the main directory
EarningsReview / Equity
- Havells India Limited (HAVL IN) by HSBC
- Q3'25: warning on weak 1E acquisition, indicates HSD % downgrades FY26 by BNP Paribas
- Itaú BBA on ALPEKA: 3Q25A Weak Quarter - Catalyst Calendar Attractive by Itau
- Itaú BBA on Chedraui: Slower Top-line Growth and Operational Deleverage in the US Drive the Miss by Itau
- Halliburton (HAL US) by HSBC
- Guidance raised on solid deal flow and positive pricing by BNP Paribas
- Tele2 - Strong cash flow but decelerating profit growth by Danske Bank Equity Research
- Q3 previews: we like Visa, Bill, and Wise into the print by BNP Paribas
- Husqvarna - Too negative view on pricing looks discounted by Danske Bank Equity Research
- FY’25 postview: 2026, year of the reset? by BNP Paribas
- Q3 Results - What to Expect? by BNP Paribas
- Prisa - 3Q25 to be weighed by FX by JB Capital Markets
- Q3'25 First Take: broadly in line; FY25 guidance confirmed by BNP Paribas
- Swedish Orphan Biovitrum - Beyfortus softens, but the rest of the portfolio shines by Danske Bank Equity Research
- 3Q results first read by BNP Paribas
- UniCredit 3Q25 results - Solid capital, good costs & strong Russia by BNP Paribas
- P&L marginal miss, FCF strong, Ichtys provision by BNP Paribas
- Solid beat & raise but generics risk remains by BNP Paribas
- 3Q25 first take: a decent quarter, 4% bottom line beat by BNP Paribas
- Q3-25 First Take by BNP Paribas
- Q325 sales: strong by BNP Paribas
- Q3-25 First Take: good flows continue before the Budget by BNP Paribas
- 3Q25 first take: a mixed performance, earnings in line with consensus by BNP Paribas
- INVEST SECURITIES - WORLDLINE : Plutôt rassurant avant le CMD du 6 novembre - SOUS REVUE by Invest Securities
- 3Q25 earnings preview by BNP Paribas